Clifford Chance has advised the Joint Global Coordinators and Joint Bookrunners on Aedifica’s EUR 380m capital increase by way of the issuance of new shares. Aedifica...
Aedifica’s €380 Million Capital Increase
Azelis’ €200 Million Capital Increase
Clifford Chance advised Azelis. Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry listed on the regulated market of Euronext...
Soitec’s Accelerated Bookbuild Offering of Ordinary Shares
Clifford Chance acted for NSIG Sunrise and BofA Securities Europe. NSIG Sunrise and BofA Securities Europe were involved in the accelerated bookbuild offering of ordinary shares...
Nicox’s €10 Million Capital Increase
Clifford Chance advised Nicox on the deal. Nicox, an international company specializing in ophthalmology, raised funds by private placement of 6,849,316 new shares, each accompanied by...
Montea’s €103 Million Accelerated Bookbuild Offering
Clifford Chance advised the underwriters involved on the deal. Montea is a Belgian real estate investment company (REIT) mainly active in logistics real estate and whose...
Nicox’ €15 Million Private Placement
Clifford Chance advised Nicox on the deal. Nicox, an international ophthalmology company, completed a financing through a private placement of 6,000,000 new shares with warrants attached...